Skin Cancer Global Clinical Trials Review, H1, 2014

News provided by

Jun 05, 2014, 04:16 ET

NEW YORK, June 5, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Skin Cancer Global Clinical Trials Review, H1, 2014

http://www.reportlinker.com/p02154181/Skin-Cancer-Global-Clinical-Trials-Review-H1-2014.html

Skin Cancer Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, "Skin Cancer Global Clinical Trials Review, H1, 2014" provides data on the Skin Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Skin Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Skin Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Introduction 6
Skin Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Skin Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Skin Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Skin Cancer 25
Subjects Recruited Over a Period of Time 39
Clinical Trials by Sponsor Type 40
Prominent Sponsors 41
Top Companies Participating in Skin Cancer Therapeutics Clinical Trials 42
Prominent Drugs 44
Latest Clinical Trials News on Skin Cancer 45
Jan 27, 2014: Immune Design Announces Treatment of First Patient in Phase 1 Clinical Trial of ID-G100, an Investigational Immuno-Oncology Agent 45
Dec 19, 2013: Blaze Bioscience Announces Initiation of First-in-Human Phase 1 Clinical Study of BLZ-100 45
Nov 06, 2013: Aclaris Therapeutics Initiates IND-Directed Program for A-101 for the Treatment of Seborrheic Keratosis, Common Type of Skin Tumor 46
Feb 11, 2013: Gefitinib Shows Promise in Treating Skin Cancer, Study Finds 46
Jan 30, 2013: Silibinin Protects Against UV-induced Skin Cancer, Researchers Report 47
Clinical Trial Profiles 48
Clinical Trial Overview of Top Companies 48
F. Hoffmann-La Roche Ltd. 48
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 48

Bristol-Myers Squibb Company 54
Clinical Trial Overview of Bristol-Myers Squibb Company 54
Novartis AG 59
Clinical Trial Overview of Novartis AG 59
GlaxoSmithKline plc 63
Clinical Trial Overview of GlaxoSmithKline plc 63
Merck & Co., Inc. 67
Clinical Trial Overview of Merck & Co., Inc. 67
Pfizer Inc. 70
Clinical Trial Overview of Pfizer Inc. 70
AstraZeneca PLC 72
Clinical Trial Overview of AstraZeneca PLC 72
Eisai Co., Ltd. 74
Clinical Trial Overview of Eisai Co., Ltd. 74
Bayer AG 76
Clinical Trial Overview of Bayer AG 76
Celgene Corporation 78
Clinical Trial Overview of Celgene Corporation 78
Clinical Trial Overview of Top Institutes / Government 79

National Cancer Institute 79
Clinical Trial Overview of National Cancer Institute 79
The University of Texas M. D. Anderson Cancer Center 102
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 102
Memorial Sloan Kettering Cancer Center 107
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 107
European Organization for Research and Treatment of Cancer 111
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 111
University of Virginia 114
Clinical Trial Overview of University of Virginia 114
Mayo Clinic 116
Clinical Trial Overview of Mayo Clinic 116
University of Pittsburgh 118
Clinical Trial Overview of University of Pittsburgh 118
Roswell Park Cancer Institute 119
Clinical Trial Overview of Roswell Park Cancer Institute 119
Eastern Cooperative Oncology Group 121
Clinical Trial Overview of Eastern Cooperative Oncology Group 121
Five Key Clinical Profiles 123
Appendix 211
Abbreviations 211
Definitions 211
Research Methodology 212
Secondary Research 212
About GlobalData 213
Contact Us 213
Disclaimer 213
Source 214

List of Tables

Skin Cancer Therapeutics, Global, Clinical Trials by Region, 2014* 7
Skin Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Skin Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Skin Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Skin Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Skin Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Skin Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Skin Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Skin Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Skin Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Skin Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Skin Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Skin Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Skin Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Skin Cancer Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Skin Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Skin Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23

Skin Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Skin Cancer Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Skin Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014* 27
Skin Cancer Therapeutics, Global, Terminated Clinical Trials, 2014* 30
Skin Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 39
Skin Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 40
Skin Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 41
Skin Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 43
Skin Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 44
Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 48
Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 54
Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 59
Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 63
Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 67
Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 70
Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 72
Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014* 74
Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 76
Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014* 78
Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 79

Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 102
Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 107
Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014* 111
Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2014* 114
Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 116
Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 118
Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2014* 119
Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 2014* 121

List of Figures

Skin Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Skin Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Skin Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Skin Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Skin Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Skin Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Skin Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Skin Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Skin Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Skin Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Skin Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Skin Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Skin Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Skin Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Skin Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Skin Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Skin Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Skin Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Skin Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 39
Skin Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 40
Skin Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 41
Skin Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 42
Skin Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 44
GlobalData Methodology 212